{
  "report_rows": [
    {
      "kpi": "Room Nights Booked (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~113-115M vs. cons 111.0M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. EBITDA Margin (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~25.2-25.5% vs. cons 24.88%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$5.30-$5.50 vs. cons $5.05",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Revenue Growth (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~7-10% vs. cons ~7.5% implied",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 EBITDA Margin Expansion (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~125-150 bps vs. cons 100-125 bps prior",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 2026 Revenue Growth (Q3 2026)",
      "prediction": "BETTER",
      "answer": "guide ~6-8% vs. cons ~-3% YoY (depressed placeholder)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Q3 2026 EBITDA Margin (Q3 2026)",
      "prediction": "BETTER",
      "answer": "guide ~+50-100 bps vs. cons ~-140 bps YoY (depressed)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 3.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 5.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 sell-side estimate upgrades on FY raise and Q3 guide vs. depressed consensus drive continued buying; partially offset by high pre-run bar",
  "day5_confidence": "MEDIUM"
}